Free Trial

Clene (CLNNW) Competitors

$0.04 0.00 (-2.26%)
As of 08/1/2025

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Clene vs. Its Competitors

Clene (NASDAQ:CLNNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

In the previous week, 180 Life Sciences had 1 more articles in the media than Clene. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Clene. 180 Life Sciences' average media sentiment score of 0.95 beat Clene's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Clene Neutral
180 Life Sciences Positive

Company Net Margins Return on Equity Return on Assets
CleneN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$350KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats Clene on 2 of the 3 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.01M$5.59B$9.53B
Dividend YieldN/A3.74%4.73%4.14%
P/E RatioN/A3.7528.9123.88
Price / SalesN/A4,302.40448.7998.82
Price / CashN/A13.1935.6858.35
Price / BookN/A39.278.165.60
Net IncomeN/A-$90.99M$3.25B$265.26M
7 Day PerformanceN/A-0.82%1.15%-0.14%
1 Month PerformanceN/A4.14%8.25%6.08%
1 Year PerformanceN/A179.01%29.18%24.22%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.04
-2.3%
N/A+30.0%$0.00$350K0.00100Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-13.2%
N/A+38.2%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/A-74.2%$0.00N/A0.002
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+57.3%$0.00$106.21K0.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-41.2%$0.00$585.60M0.004Positive News
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/A-24.8%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.15
-2.6%
N/A+214.7%$0.00$38.00M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.02
+19.3%
N/A-99.0%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.03
-12.0%
N/A-79.9%$0.00N/A0.008Positive News
Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners